Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on February 7, 2005

Hypertension. 2005
Published online before print February 7, 2005, doi: 10.1161/01.HYP.0000154786.17416.ea
A more recent version of this article appeared on April 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/4/799    most recent
01.HYP.0000154786.17416.eav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, X.
Right arrow Articles by Rotter, J. I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, X.
Right arrow Articles by Rotter, J. I
Related Collections
Right arrow Risk Factors
Right arrow Hypertension - basic studies
Right arrow Type 2 diabetes
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease

Submitted on October 12, 2004
Revised on November 8, 2004

Hypertension Genes Are Genetic Markers for Insulin Sensitivity and Resistance

Xiuqing Guo*; Suzanne Cheng; Kent D. Taylor; Jinrui Cui; Randall Hughes; Manuel J. Quiñones; Isabel Bulnes-Enriquez; Roxana De La Rosa; George Aurea; Huiying Yang; Willa Hsueh; and Jerome I Rotter

From the Medical Genetics Institute (X.G., K.D.T., J.C., H.Y., J.I.R.), Spielberg Pediatrics Research Center, Cedars-Sinai Medical Center; the Department of Pediatrics (X.G., K.D.T., H.Y., J.I.R.) and the Department of Medicine (M.J.Q., I.B.-E., R.D.L.R., G.A., W.H.), David Geffen School of Medicine at UCLA, Los Angeles, Calif; and the Department of Human Genetics (S.C., R.H.), Roche Molecular Systems Inc, Alameda, Calif.

* To whom correspondence should be addressed. E-mail: Xiuqing.Guo{at}cshs.org.

Abstract--Insulin resistance is a determinant of blood pressure variation and risk factor for hypertension. Because insulin resistance and blood pressure cosegregate in Mexican American families, we thus investigated the association between variations in 9 previously reported hypertension genes (ACE, AGT, AGTRI, ADDI, NPPA, ADDRB2, SCNN1A, GNB3, and NOS3) and insulin resistance. Families were ascertained via a coronary artery disease proband in the Mexican American Coronary Artery Disease Project. Individuals from 100 Mexican American families (n=656) were genotyped for 14 polymorphisms in the 9 genes and all adult offspring and offspring spouses were phenotyped for insulin sensitivity by hyperinsulinemic euglycemic clamp (n=449). AGT M235T and NOS3 A(-922)G and E298D polymorphisms were significantly associated with insulin sensitivity (P=0.018, 0.036, 0.039) but were not significant after adjusting for body mass index. ADD1 G460W was associated with insulin sensitivity only after adjusting for body mass index. The NPPA T2238C and SCNN1A A663T were associated with decreased fasting insulin levels after adjusting for body mass index (P=0.015 and 0.028). In conclusion, AGT, NOS3, NPPA, ADRB2, ADD1, and SCNN1A may well be genetic markers for insulin resistance, and adiposity was a potential modifier for only some gene/trait combinations. Our data support the hypothesis that genes in the blood pressure pathway may play a role in insulin resistance in Mexican Americans.


Key words: genetics • hypertension • insulin resistance • risk factors




This article has been cited by other articles:


Home page
Diabetes and Vascular Disease ResearchHome page
F. Thameem, S. Puppala, N. H Arar, M. P Stern, J. Blangero, R. Duggirala, and H. E Abboud
Endothelial nitric oxide synthase (eNOS) gene polymorphisms and their association with type 2 diabetes-related traits in Mexican Americans
Diabetes and Vascular Disease Research, June 1, 2008; 5(2): 109 - 113.
[Abstract] [PDF]


Home page
HypertensionHome page
P.-a. B. Shih and D. T. O'Connor
Hereditary Determinants of Human Hypertension: Strategies in the Setting of Genetic Complexity
Hypertension, June 1, 2008; 51(6): 1456 - 1464.
[Full Text] [PDF]


Home page
JAMAHome page
A. I. Lynch, E. Boerwinkle, B. R. Davis, C. E. Ford, J. H. Eckfeldt, C. Leiendecker-Foster, and D. K. Arnett
Pharmacogenetic Association of the NPPA T2238C Genetic Variant With Cardiovascular Disease Outcomes in Patients With Hypertension
JAMA, January 23, 2008; 299(3): 296 - 307.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Vassalle, M. G. Andreassi, C. Prontera, M. Fontana, L. Zyw, C. Passino, and M. Emdin
Influence of ScaI and Natriuretic Peptide (NP) Clearance Receptor Polymorphisms of the NP System on NP Concentration in Chronic Heart Failure
Clin. Chem., November 1, 2007; 53(11): 1886 - 1890.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
P. Margozzini, A. Rigotti, C. Ferreccio, N. Quezada, M. Garrido, and G. Valdes
Review: Hypertension and the cardiometabolic syndrome in Chile: a review of concepts and consequences for the developing world
Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 83 - 90.
[Abstract] [PDF]


Home page
HypertensionHome page
J.-J. Hottenga, J. B. Whitfield, D. Posthuma, G. Willemsen, E. J.C. de Geus, N. G. Martin, and D. I. Boomsma
Genome-Wide Scan for Blood Pressure in Australian and Dutch Subjects Suggests Linkage at 5P, 14Q, and 17P
Hypertension, April 1, 2007; 49(4): 832 - 838.
[Abstract] [Full Text] [PDF]